Medical University of South Carolina
Cardiovascular Disease fellowship · Charleston, SC · Program website
This program's roster hasn't been collected yet, so there's no list of its own faculty and papers. Below is Medical University of South Carolina's research in cardiovascular disease, which the program shares with other departments and affiliated hospitals.
About Medical University of South Carolinainstitution-wide cardiovascular disease research
Cardiovascular Disease publications from Medical University of South Carolina and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
163
works per year
21st of 78 cardiovascular disease fellowship programs
+6.3%
2-year growth
48th of 78 cardiovascular disease fellowship programs
36.2%
in top 10% of field (works before 2025)
8th of 74 cardiovascular disease fellowship programs
55.6%
cited above world average
5th of 74 cardiovascular disease fellowship programs
Works per year · * 2026 so far
Cardiology and Cardiovascular Medicine · 805
Cardiovascular Disease research topics at Medical University of South Carolina
Papers in the window; each links to the list on OpenAlex.
- Heart Failure Treatment and Management 195
- Cardiac pacing and defibrillation studies 79
- Atrial Fibrillation Management and Outcomes 77
- Cardiac Valve Diseases and Treatments 70
- Cardiomyopathy and Myosin Studies 45
- Blood Pressure and Hypertension Studies 44
- Cardiac Arrhythmias and Treatments 44
- Cardiac Fibrosis and Remodeling 31
Most cited at Medical University of South Carolina since 2024
All cardiovascular disease papers there on OpenAlex
- Tirzepatide for Heart Failure with Preserved Ejection Fraction and ObesityMilton Packer et al. · New England Journal of Medicine · 2024 · PubMed · cited 1,058
- Apixaban to Prevent Recurrence After Cryptogenic Stroke in Patients With Atrial CardiopathyHooman Kamel et al. · JAMA · 2024 · PubMed · cited 223
- Tirzepatide Reduces LV Mass and Paracardiac Adipose Tissue in Obesity-Related Heart FailureChristopher M. Kramer et al. · Journal of the American College of Cardiology · 2024 · PubMed · cited 197
- Transcatheter aortic valve implantation in patients with high-risk symptomatic native aortic regurgitation (ALIGN-AR): a prospective, multicentre, single-arm studyTorsten Peter Vahl et al. · The Lancet · 2024 · PubMed · cited 175
- Effects of tirzepatide on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trialBarry A. Borlaug et al. · Nature Medicine · 2024 · PubMed · cited 161
- 2025 American Society of Anesthesiologists Practice Advisory for Perioperative Care of Older Adults Scheduled for Inpatient SurgeryFrederick E. Sieber et al. · Anesthesiology · 2024 · PubMed · cited 125
- Near-universal prevalence of central adiposity in heart failure with preserved ejection fraction: the PARAGON-HF trialAlexander Peikert et al. · European Heart Journal · 2025 · PubMed · cited 120
- An evidence-based screening tool for heart failure with preserved ejection fraction: the HFpEF-ABA scoreYogesh N.V. Reddy et al. · Nature Medicine · 2024 · PubMed · cited 118
- Pulsed Field vs Conventional Thermal Ablation for Paroxysmal Atrial FibrillationVivek Yerrapu Reddy et al. · Journal of the American College of Cardiology · 2024 · PubMed · cited 104
- Implantable Hemodynamic Monitors Improve Survival in Patients With Heart Failure and Reduced Ejection FractionJoAnn M. Lindenfeld et al. · Journal of the American College of Cardiology · 2024 · PubMed · cited 89